Relaxin 2 Protein (RLN2) (His tag)

Produktnummer ABIN1098720

Produktdetails

Target: Relaxin 2 (RLN2)

Protein-Typ: Recombinant

Spezies: Human

Quelle: Escherichia coli (E. coli)

Aufreinigungstag / Konjugat: Dieses Relaxin 2 Protein ist gelabelt mit His tag.

Applikation: SDS-PAGE (SDS)

Reinheit: > 85 % by SDS - PAGE

Anwendungsinformationen

Kommentare:

Synonyms: Prorelaxin H2 isoform, bA12D24.1.1, bA12D24.1.2, H2, RLXH2

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 mg/ml (determined by Bradford assay)

Buffer: 20 mM Tris-HCl buffer (pH 8.0) containing 0.4 M Urea, 10% glycerol

Lagerung: 4 °C

Informationen zur Lagerung: Avoid repeated freezing and thawing cycles.

Antigendetails

Target: Relaxin 2 (RLN2)

Andere Bezeichnung: RLN2 (RLN2 Produkte)

Synonyme: H2 Protein, H2-RLX Protein, RLXH2 Protein, bA12D24.1.1 Protein, bA12D24.1.2 Protein, RFLX Protein, rln2 Protein, rln3c Protein, rlx3c Protein, si:rp71-39b20.5 Protein, relaxin 2 Protein, insulin-like 3 (Leydig cell) Protein, RLN2 Protein, insl3 Protein

Hintergrund: Prorelaxin H2, also known as RLN2, belongs to the insulin gene superfamily. This family is produced by the ovary, and targets the mammalian reproductive system to ripen the cervix, elongate the pubic symphysis and inhibit uterine contraction. It may have additional roles in enhancing sperm motility, regulating blood pressure, controlling heart rate and releasing oxytocin and vasopressin. RLN2 is a peptide hormone associated with a number of therapeutically relevant physiological effects, including regulation of collagen metabolism and multiple vascular control pathways. RLN1 and RLN2 share high sequence homology. Recombinant human RLN2 protein, fused to His-tag at N-terminus, was expressed in E.coli.

Molekulargewicht: 20.7 kDa (184aa)

NCBI Accession: NP_604390

Pathways: Hormone Activity